Pharmanex® Scientists Create Innovative Products
Pharmanex® created eight new and innovative products in 2005, including g3™ superfruit juice, Xoi Bar™, lifepak® nano, and DuoLean™. In addition, R&D is about to conclude two years of efforts to improve our BioPhotonic Scanner technology, resulting in the new S2 model, which will be officially launched in early March 2006. Finally, R&D aggressively pursued product registrations in preparation for the much anticipated Pharmanex® launch in Russia (2006). Pharmanex® R&D currently maintains a solid new product pipeline with strong innovative projects being prepared for the future.

Pharmanex® Scientists Perform More Studies than Ever
Our clinical and pharmacological laboratories in Beijing and Provo conducted 16 human clinical studies, 190 experimental and pre-clinical studies, 20 toxicology studies and developed 19 new biological efficacy testing methods. Compared to the previous year, the number of studies was significantly greater. For example, we have performed almost twice the number of clinical studies and over ten times more preclinical studies in 2005.

> read more

On October 18, 1998, Pharmanex was acquired by Nu Skin Enterprises, Inc. (NYSE: NUS), a leading direct sales company.